Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00128622 | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | H. Kim LyerlyOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00480584 | A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer | completed | Phase 1 | 20 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 8, 2012 | clinicaltrials |
| NCT00547144 | Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer | completed | Phase 1 | 2 | George Albert FisherOTHER | 1 | Nov 8, 2012 | clinicaltrials |
| NCT00709826 | APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer | completed | Phase 2 | 109 | Tragara Pharmaceuticals, Inc.INDUSTRY | 1 | Nov 7, 2012 | clinicaltrials |
| NCT00498225 | Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer(GEST) | completed | Phase 3 | 834 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 2 | Nov 2, 2012 | clinicaltrials |
| NCT01256034 | Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy(EPIPD) | completed | Phase 4 | 50 | Chiba UniversityOTHER | 1 | Oct 23, 2012 | clinicaltrials |
| NCT00578279 | Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study | completed | Phase 4 | 20 | Indiana UniversityOTHER | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01161186 | Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma | completed | Phase 1 | 15 | University of California, San FranciscoOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT01703026 | Contrast Enhanced EUS in the Evaluation of Pancreatic Cancer and Pancreatic Masses | completed | — | 33 | Changi General HospitalOTHER | 1 | Oct 10, 2012 | clinicaltrials |
| NCT00862524 | A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer | completed | Phase 1 / Phase 2 | 20 | Array BioPharmaINDUSTRY | 1 | Oct 4, 2012 | clinicaltrials |
| NCT01048320 | Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer(RPGOG1) | completed | Phase 1 | 36 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00004884 | Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | completed | Phase 2 | 96 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00005053 | Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 35 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00064207 | Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 97 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00126633 | Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 53 | University of California, San FranciscoOTHER | 1 | Sep 17, 2012 | clinicaltrials |
| NCT00577564 | EUS-CPN: A Retrospective Review | completed | — | — | Indiana UniversityOTHER | 1 | Sep 12, 2012 | clinicaltrials |
| NCT00583479 | Prospective Study of Celiac Block Injection: 1 vs. 2 | completed | Phase 4 | 100 | Indiana UniversityOTHER | 1 | Sep 12, 2012 | clinicaltrials |
| NCT01186731 | Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 40 | INSYS Therapeutics IncINDUSTRY | 1 | Sep 12, 2012 | clinicaltrials |
| NCT01041235 | Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies | completed | Phase 1 | 29 | Azaya Therapeutics, Inc.INDUSTRY | 1 | Sep 6, 2012 | clinicaltrials |
| NCT00004861 | Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | — | PfizerINDUSTRY | 2 | Aug 10, 2012 | clinicaltrials |
| NCT00003760 | Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer | completed | Phase 2 | 3 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00047710 | Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer | completed | Phase 1 | 48 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00003046 | Interleukin-12 in Treating Patients With Cancer in the Abdomen | completed | Phase 1 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT01196247 | A Study of Therapy Selected by Molecular/Metabolic Profiling in Patients With Previously Treated Metastatic Pancreatic Cancer | completed | Phase 2 | 35 | Translational Drug DevelopmentOTHER | 1 | Jul 17, 2012 | clinicaltrials |
| NCT00529984 | A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies(CEA(6D)VRP) | completed | Phase 1 / Phase 2 | 28 | AlphaVax, Inc.INDUSTRY | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00837239 | Huachansu & Gemcitabine in Pancreatic Cancer | completed | Phase 2 | 80 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00003029 | Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | completed | Phase 3 | 200 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 2, 2012 | clinicaltrials |
| NCT00024427 | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer | completed | Phase 3 | 250 | Wellstat TherapeuticsINDUSTRY | 2 | Jun 28, 2012 | clinicaltrials |
| NCT00767273 | Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx | completed | N/A | 30 | Stanford UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00004895 | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004910 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00556023 | A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer | completed | Phase 1 | 37 | AstraZenecaINDUSTRY | 2 | Jun 6, 2012 | clinicaltrials |
| NCT00467116 | PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca | completed | Phase 1 | 9 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00003951 | DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas | completed | Phase 2 | 37 | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00023972 | Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | — | Daiichi SankyoINDUSTRY | 3 | May 16, 2012 | clinicaltrials |
| NCT00427752 | Abdominal Exploration Without Incisions | completed | Early Phase 1 | 20 | Jeffrey HazeyOTHER | 1 | May 7, 2012 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT01051284 | A Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer | completed | Phase 1 | 14 | Georgetown UniversityOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00626158 | Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers | completed | Phase 1 | 45 | University of California, San FranciscoOTHER | 1 | Apr 4, 2012 | clinicaltrials |
| NCT01320241 | Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture | completed | Phase 2 | 24 | Southeast University, ChinaOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT00499265 | Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 95 | Heidelberg Pharma AGINDUSTRY | 6 | Mar 29, 2012 | clinicaltrials |
| NCT00660205 | Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer(GIVTE) | completed | — | 285 | University of AarhusOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019513 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | completed | Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00547612 | Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer | completed | Phase 1 | 33 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00559598 | Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer | completed | — | 502 | National Institutes of Health Clinical Center (CC)NIH | 0 | Mar 8, 2012 | clinicaltrials |
| NCT00266097 | Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | completed | Phase 1 | 23 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 7, 2012 | clinicaltrials |
| NCT01543412 | Second Line Chemotherapy for Advanced Pancreatic Cancer(SLAP) | completed | Phase 2 | 50 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Mar 5, 2012 | clinicaltrials |
| NCT00051467 | A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer | completed | Phase 3 | — | GenVecINDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00068575 | Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | completed | Phase 2 | 29 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00913198 | A Study of CP-4126 in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 21 | Clavis PharmaINDUSTRY | 2 | Feb 10, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Nov 12, 2012source: clinicaltrials